MedPath

Calorie restriction and plasma brain-derived neurotrophic factor

Not Applicable
Conditions
Hypertension.
Essential (primary) hypertension
Registration Number
IRCT20160702028742N11
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
52
Inclusion Criteria

Patients with a body mass index higher than 25
Regular use of antihypertensive drugs for at least the last 3 months
non-smoker
Haven't been under any weight-loss diet at least 3 months before participating in the study

Exclusion Criteria

Taking antipsychotic, anticonvulsant drugs
Cancer or stage 4 or 5 chronic or kidney disease
Pregnancy or breastfeeding
Any changes in the disease treatment plan during the study, including changes in the type and dose of drugs used to affect blood pressure or surgery•
Insulin treated patients
Taking omega 3 supplement

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood pressure. Timepoint: Baseline and the end of study. Method of measurement: Validated digital arm sphygmomanometer.
Secondary Outcome Measures
NameTimeMethod
Plasma brain-derived neurotrophic factor. Timepoint: Baseline and the end of study. Method of measurement: ?»]??.;Plasma ICAM-1. Timepoint: Baseline and the end of study. Method of measurement: ELISA.
© Copyright 2025. All Rights Reserved by MedPath